Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 378.00M | $ 90.30M | $ 53.90M | $ 33.80M | $ 22.70M |
Total Assets | $ 12.08B | $ 11.55B | $ 11.18B | $ 11.02B | $ 10.85B |
Total Debt | $ 7.13B | $ 6.73B | $ 6.39B | $ 6.62B | $ 6.44B |
Net Debt | $ 6.75B | $ 6.64B | $ 6.33B | $ 6.58B | $ 6.42B |
Total Liabilities | $ 10.87B | $ 10.29B | $ 10.03B | $ 9.88B | $ 9.83B |
Stockholders Equity | $ 1.21B | $ 1.26B | $ 1.15B | $ 1.14B | $ 1.02B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |